Clinical Trial Update: DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting

View source ↗

Summary

DemonsTTRate is a global, observational, multicenter study to collect long-term real-world data on patients with transthyretin amyloidosis with cardiomyopathy. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transthyretin Amyloidosis with Cardiomyopathy

Snippet

Sponsor: Alnylam Pharmaceuticals | Conditions: Transthyretin Amyloidosis With Cardiomyopathy | Status: RECRUITING